NASDAQ: CLOVClover Health Investments Corp Stock
$5.00+0.20 (+4.17%)
Updated Jun 18, 2026
CLOV Price
$5.00
Fair Value Price
-$3.37
Market Cap
$2.63B
52 Week Low
$1.58
52 Week High
$5.18
P/E
-41.67x
P/B
7.76x
P/S
0.42x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.21B
Earnings
-$56.94M
Gross Margin
18.4%
Operating Margin
-2.58%
Profit Margin
-2.6%
Debt to Equity
1.06
Operating Cash Flow
$57M
Beta
1.54
Next Earnings
Aug 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A
CLOV Overview
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CLOV's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Healthcare Plan
Industry Rating
A
CLOV
Ranked#6 of 10
Ranked#6 of 10
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $28.40 | A | |
| $61.02 | B | |
| $21.86 | B |
Be the first to know about important CLOV news, forecast changes, insider trades & much more!
CLOV News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CLOV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CLOV ($5.00) is overvalued by 248.31% relative to our estimate of its Fair Value price of -$3.37 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CLOV ($5.00) is not significantly undervalued (248.31%) relative to our estimate of its Fair Value price of -$3.37 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CLOV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CLOV due diligence checks available for Premium users.
Valuation
CLOV fair value
Fair Value of CLOV stock based on Discounted Cash Flow (DCF)
Price
$5.00
Fair Value
-$3.37
Undervalued by
248.31%
CLOV ($5.00) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CLOV ($5.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CLOV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CLOV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-41.67x
Industry
27.99x
Market
9.47x
CLOV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.76x
Industry
2.43x
CLOV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CLOV's financial health
Profit margin
Revenue
$749.2M
Net Income
$27.3M
Profit Margin
3.6%
CLOV's Earnings (EBIT) of -$56.94M... subscribe to Premium to read more.
Interest Coverage Financials
CLOV's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$697.7M
Liabilities
$358.3M
Debt to equity
1.06
CLOV's short-term assets ($448.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLOV's short-term assets ($448.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLOV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CLOV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$107.9M
Investing
-$5.1M
Financing
-$7.9M
CLOV's operating cash flow ($57.25M)... subscribe to Premium to read more.
Debt Coverage Financials
CLOV vs Healthcare Plan Stocks
Clover Health Investments Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.